FRM
IDYA icon

Fox Run Management’s IDEAYA Biosciences IDYA Stock Holding History

Fox Run Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,730
Closed -$495K – 1103
2026
Q1 		$495K Buy
+15,730
New +$528K 0.09% 443
2025
Q4 		– Sell
-12,105
Closed -$329K – 1065
2025
Q3 		$329K Buy
+12,105
New +$293K 0.05% 655
2024
Q1 		– Sell
-6,845
Closed -$244K – 913
2023
Q4 		$244K Buy
+6,845
New +$204K 0.06% 570

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fox Run Management's IDYA Position: Q2 2026 in Review

Fox Run Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 15,730 shares — an estimated $495K sold.

Fox Run Management first reported a position in IDYA in Q4 2023 and held it in 3 quarters. The position peaked at $495K in Q1 2026. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Fox Run Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 15,730 IDEAYA Biosciences shares in Q2 2026, an estimated $495K.
  • Fox Run Management first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 3 quarters.
  • Fox Run Management's IDEAYA Biosciences position peaked at $495K in Q1 2026.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.